Evidence map›Paper›PMID 31557932›Full record

ArticleMicromachines2019

A Microfluidic Deformability Assessment of Pathological Red Blood Cells Flowing in a Hyperbolic Converging Microchannel.

Vera Faustino, Raquel O Rodrigues, Diana Pinho, Elísio Costa, Alice Santos-Silva, Vasco Miranda, Joana S Amaral, Rui Lima

Open access · goldAbstract read
In one paragraph

Article in Micromachines, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Measuring cell deformation by microfluidics.Frontiers in bioengineering and biotechnology · 2023
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Vera FaustinoCenter for MicroElectromechanical Systems (CMEMS-UMinho), University of Minho, Campus de Azurém, 4800-058 Guimarães, Portugal. id5778@alunos.uminho.pt.ORCID 0000-0001-9041-2188
Raquel O RodriguesCenter for MicroElectromechanical Systems (CMEMS-UMinho), University of Minho, Campus de Azurém, 4800-058 Guimarães, Portugal. d8605@dei.uminho.pt.ORCID 0000-0003-4493-2654
Diana PinhoCenter for MicroElectromechanical Systems (CMEMS-UMinho), University of Minho, Campus de Azurém, 4800-058 Guimarães, Portugal. diana@ipb.pt.ORCID 0000-0002-3884-6496
Elísio CostaUCIBIO-REQUINTE, Faculty of Pharmacy of University of Porto, Rua de Jorge Viterbo Ferreira, 4150-755 Porto, Portugal. emcosta@ff.up.pt.
Alice Santos-SilvaUCIBIO-REQUINTE, Faculty of Pharmacy of University of Porto, Rua de Jorge Viterbo Ferreira, 4150-755 Porto, Portugal. assilva@ff.up.pt.
Vasco MirandaDialysis Clinic of Gondomar, Rua 5 de Outubro, 4420-086 Gondomar, Portugal. mail@vascomiranda.com.
Joana S AmaralCIMO, Centro de Investigação de Montanha, Instituto Politécnico de Bragança, Campus de Sta. Apolónia, 5300-253 Bragança, Portugal. jamaral@ipb.pt.ORCID 0000-0002-3648-7303
Rui LimaMEtRICs, Mechanical Engineering Department, University of Minho, Campus de Azurém, 4800-058 Guimarães, Portugal. rl@dem.uminho.pt.ORCID 0000-0003-3428-637X
Universidade do Porto · PTUniversity of Minho · PTPolytechnic Institute of Bragança · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The loss of the red blood cells (RBCs) deformability is related with many human diseases, such as malaria, hereditary spherocytosis, sickle cell disease, or renal diseases. Hence, during the last years, a variety of technologies have been proposed to gain insights into the factors affecting the RBCs deformability and their possible direct association with several blood pathologies. In this work, we present a simple microfluidic tool that provides the assessment of motions and deformations of RBCs of end-stage kidney disease (ESKD) patients, under a well-controlled microenvironment. All of the flow studies were performed within a hyperbolic converging microchannels where single-cell deformability was assessed under a controlled homogeneous extensional flow field. By using a passive microfluidic device, RBCs passing through a hyperbolic-shaped contraction were measured by a high-speed video microscopy system, and the velocities and deformability ratios (DR) calculated. Blood samples from 27 individuals, including seven healthy controls and 20 having ESKD with or without diabetes, were analysed. The obtained data indicates that the proposed device is able to detect changes in DR of the RBCs, allowing for distinguishing the samples from the healthy controls and the patients. Overall, the deformability of ESKD patients with and without diabetes type II is lower in comparison with the RBCs from the healthy controls, with this difference being more evident for the group of ESKD patients with diabetes. RBCs from ESKD patients without diabetes elongate on average 8% less, within the hyperbolic contraction, as compared to healthy controls; whereas, RBCs from ESKD patients with diabetes elongate on average 14% less than the healthy controls. The proposed strategy can be easily transformed into a simple and inexpensive diagnostic microfluidic system to assess blood cells deformability due to the huge progress in image processing and high-speed microvisualization technology.

Indexed as

blood on chipscell deformabilitychronic renal diseasediabeteshyperbolic microchannelmicrofluidic devicesred blood cells (RBCs)

Identifiers

PMID31557932
PMCPMC6843121
OpenAlexW2975270498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.